Twin Tree Management, LP Crispr Therapeutics Ag Transaction History

Twin Tree Management, LP

  • $50 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $1.54 Million - $2.87 Million
39,772 New
39,772 $2.49 Million
Q4 2022

Feb 13, 2023
SELL
$39.19 - $65.67 $3.13 Million - $5.25 Million
-79,939 Reduced 62.69%
47,585 $1.93 Million
Q3 2022

Nov 10, 2022
BUY
$61.1 - $83.78 $7.79 Million - $10.7 Million
127,524 New
127,524 $8.33 Million

Others Institutions Holding CRSP

# of Institutions
487
Shares Held
58M
Call Options Held
1.09M
Put Options Held
1.9M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.26B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email